We must pivot from developing drugs to commercialising the platform
Value proposition: Enhance existing drugs to address a large and growing $250Bn USD market
1. Bring drugs to the right place (i.e., to intracellular targets)
2. Enhance properties of drugs (e.g., improve therapeutic window)
3. Reduce discovery cycle time (strongly improving profile)
To view Presentation please download PDF attached:
Download this document
